documents: FDA-2011-N-0326-0024

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2011-N-0326-0024 FDA FDA-2011-N-0326 Recommendations for User Fee Programs: Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 Through 2017; Meeting Notice Public Meetings 2011-12-07T05:00:00Z 2011 12 2011-12-07T05:00:00Z 2012-01-07T04:59:59Z 2012-03-24T19:31:36Z 2011-31499 0 0 0900006480f7d578

Links from other tables